Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak
- 5 July 2010
- journal article
- Published by Taylor & Francis Ltd in International Journal of Radiation Biology
- Vol. 86 (9), 742-751
- https://doi.org/10.3109/09553002.2010.481322
Abstract
Purpose: To analyse changes of cell inactivation and proliferation under therapeutic irradiation conditions along the proton spread out Bragg peak (SOBP) with particular emphasis on its distal declining edge. Materials and methods: HTB140 cells were irradiated at four positions: plateau, middle, distal end and distal declining edge of the 62 MeV proton SOBP. Doses ranged from 2–16 Gy. They were normalised in the middle of SOBP and delivered following the axial physical dose profile. Survival, proliferation and cell cycle were assessed seven days after irradiation. Results: Moving from proximal to distal irradiation position surviving fractions at 2 Gy (SF2) decreased from 0.88–0.59. Increased radiosensitivity of the cells was noticed for the doses below 4 Gy, resulting in two gradients of cell inactivation, stronger for lower and weaker for higher doses. Relative biological effectiveness (RBE) increased from 1.68–2.84 at the distal end of SOBP. A further rise of RBE reaching 7.14 was at its distal declining edge. Following the axial physical dose profile of SOBP the strongest inactivation was attained at its distal end and was comparable to that at its declining edge. Conclusions: Survival data confirmed very high radioresistance of HTB140 cells. An effect similar to low-dose hyper radiosensitivity (HRS) was observed for order of magnitude larger doses. Better response of cells to protons than to γ-rays was illustrated by rather high RBE. Strong killing ability at the SOBP distal declining edge was the consequence of increasing proton linear energy transfer.Keywords
This publication has 32 references indexed in Scilit:
- Analysis of cell cycle phases and progression in cultured mammalian cellsMethods, 2007
- Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beamInternational Journal of Radiation Biology, 2006
- Apoptosis induced by low-dose and low-dose-rate radiationCancer, 2002
- Radiobiological studies on the 65MeV therapeutic proton beam at Nice using human tumour cellsInternational Journal of Radiation Biology, 2000
- Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased radioresistanceInternational Journal of Radiation Biology, 2000
- Inactivation of human normal and tumour cells irradiated with low energy protonsInternational Journal of Radiation Biology, 2000
- Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trialEuropean Journal of Cancer, 1998
- Radiosensitivity of new and established human melanoma cell lines: Comparison of [3H]thymidine incorporation and soft agar clonogenic assaysEuropean Journal of Cancer, 1994
- The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protonsThe British Journal of Radiology, 1994
- Energy loss, range, path length, time-of-flight, straggling, multiple scattering, and nuclear interaction probability: In two parts. Part 1. For 63 compounds Part 2. For elements 1 ⩽ Z ⩽ 92Atomic Data and Nuclear Data Tables, 1982